Answers are grounded in this paper and cite their sources.
Examines imaging efficiency of EphA2-targeted PET radiotracer in tumors, suggesting novel diagnostic pathways.
Cu]Cu-DOTA-TYPE7 as a promising PET tracer for imaging EphA2-expressing diseases and provides a foundation for future development of EphA2-targeted theranostic applications.
No takes yet. Share an insight, caveat, or question.
Sanwick et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: